New York Presbyterian Hospital Program

The New York Presbyterian Hospital (NYPH)/Columbia University Irving Medical Center (CUIMC) Laboratory Genetics and Genomics (LGG) Program is an ACGME-accredited fellowship training program aimed at nurturing the next generation of genomics healthcare professionals. Established from roots in Clinical Cytogenetics and Clinical Molecular Genetics, the LGG program emphasizes innovative clinical care and precision medicine research, thereby serving the community-and global healthcare landscape.

During the two-year training period, fellows immerse themselves in a hands-on experience, gaining practical skills in clinical assays, test results evaluation, participating in quality assurance, and validating new assays. Training involves a plethora of technologies including karyotyping, copy number microarrays, FISH testing, Southern blotting, PCR-RFLP, Sanger sequencing, high-throughput genotyping, and next-generation sequencing during the program duration 1.

The curriculum is multifaceted, including participation in multiple conferences such as the Chief of Service Conference, Clinical Genetics Conferences, and Tumor Board, along with didactic lectures covering Clinical Pathology, Clinical Genetics, and Genomics. This structured approach equips fellows with the knowledge and expertise necessary for the field of genomic medicine 1.

Requirements and Applicant Eligibility

Applicants to the LGG fellowship must hold either an M.D. or a Ph.D. (or equivalent) in genetics, molecular biology, or related biological sciences. For candidates with degrees obtained outside the United States or Canada, conditions are stringent as credential approvals from the ABMGG Credentials Committee are mandatory before entry into the fellowship program. Additionally, an ideal candidate should possess clinical laboratory or research experience coupled with a robust publication record and excellent communication skills, with a commitment to the fellowship’s two-year intensive training 1.

Visa Support and Competitiveness

The program is competitive, welcoming applications from both U.S. medical graduates and international candidates. However, it should be noted that only J1 visas are accepted for international applicants, thereby enforcing a framework that ensures compliant and qualified participants in the fellowship 1.

Application Details

Each academic year typically offers one available position for fellowship, commencing on July 1st, and the application process must be completed by September 30th of the preceding year. Applications must include a comprehensive curriculum vitae, a personal statement, three recommendation letters, and a credential approval letter from ABMGG for foreign degree holders 1.

Unique Aspects of the Program

The Laboratory Genetics and Genomics Program at NYPH/CUIMC is distinctive not only for its accredited status but also due to the breadth of learning experiences it offers. Fellows participate in clinically oriented research projects throughout their training and gain profound insights into both constitutional and oncology genomics. The program aims to mold fellows into well-rounded clinician-scientists, integrating technical proficiency with interdisciplinary clinical knowledge, making them valuable assets to multi-faceted healthcare teams 1.

Fellowship Outcomes

The fellowship not only enhances clinical competence but prepares fellows for impactful roles in both academic and industry settings. Graduates become adept practitioners in Genomic Medicine, equipped with both the theoretical and practical backgrounds necessary to excel in their future careers 1.

The LGG program is among the premier training opportunities available within New York Presbyterian Hospital, uniting academic excellence, rigorous training, and pioneering research to advance the fields of genetics and genomics.